Island Pharmaceuticals Ltd has released a press release.
ISLA101 drug product achieves stability milestone
Filed with ASX ·
6ix hasn’t read this filing yet.
Island Pharmaceuticals Ltd on 6ix
In the deck
Earlier from Island Pharmaceuticals
- ILA granted key Canadian patent for ISLA-101
- Positive analytical results for ISLA-101 capsules
- ISLA-101 manufacturing progress
- ISLA-101 manufacturing and timeline update
- Island executes PEACH clinical study CRO agreement
Later from Island Pharmaceuticals
- IRB approval received for ISLA101 Phase 2a clinical trial
- ILA submits IND to US FDA for Phase 2a PEACH clinical trial
- Island receives FDA feedback on Phase 2a clinical study
- ILA receives additional FDA feedback on IND for ISLA 101
- Island submits responses to FDA questions for ISLA-101
Follow Island Pharmaceuticals into a list and get an email when it puts out news.
Follow Island Pharmaceuticals